Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930)
😃Good
Catalog No. TMAB-01659
Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930) is a Rabbit antibody targeting SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized. Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930) can be used in WB.
Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930)
Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930)
😃Good
Catalog No. TMAB-01659
Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930) is a Rabbit antibody targeting SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized. Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930) can be used in WB.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 μL | $273 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Antigen Details
Chemical Properties
| Description | Antibody Type: Recombinant Rabbit Monoclonal Application: WB Reactivity: SARS-CoV-2 WT,SARS-CoV-2 (D614G),SARS-CoV-2 Omicron and series of mutants |
| Ig Type | IgG |
| Clone | 6F930 |
| Reactivity | SARS-CoV-2 WT,SARS-CoV-2 (D614G),SARS-CoV-2 Omicron and series of mutants |
| Verified Activity | 1. Sample: Lane 1: Recombinant SARS-CoV-2 N Protein (Omicron (B.1.1.529) (P13L,E31del,R32del, S33del,R203K,G204R) at 100ng Lane 2: Recombinant SARS-CoV-2 N Protein (Omicron (B.1.1.529) (P13L,E31del,R32del, S33del,R203K,G204R) at 50ng Lane 3: Recombinant SARS-CoV-2 N Protein (Omicron (B.1.1.529) (P13L,E31del,R32del, S33del,R203K,G204R) at 25ng Lane 4: Recombinant SARS-CoV-2 N Protein (Omicron (B.1.1.529) (P13L,E31del,R32del, S33del,R203K,G204R) at 10ng Lane 5: Recombinant SARS-CoV-2 N Protein (Omicron (B.1.1.529) (P13L,E31del,R32del, S33del,R203K,G204R) at 5ng Lane 6: Recombinant SARS-CoV-2 N Protein (WT) at 10ng Primary: Rabbit Anti-SARS-CoV-2 N protein (TMAB-01659) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size:45.3 kDa Observed band size:50 kDa 2. Sample: Lane 1: SARS-CoV-2 N Protein (WT) at 10ng Lane 2: SARS-CoV-2 N Protein (Del204 & Del215) at 2ng Lane 3: SARS-CoV-2 N Protein (R203M & D377Y) at 2ng Primary: Rabbit Anti-SARS-CoV-2 N Protein Antibody at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size:46 kDa Observed band size:46 kDa 3. Sample: Lane 1: SARS-CoV-2 N Protein (WT) at 10ng Lane 2: SARS-CoV-2 N Protein (Del204 & Del215) at 10ng Lane 3: SARS-CoV-2 N Protein (R203M & D377Y) at 10ng Primary: Rabbit Anti-SARS-CoV-2 N Protein Antibody at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size:46 kDa Observed band size:46 kDa 4. The purity of the protein is greater than 90% as determined by reducing SDS-PAGE. 5. The purity of the protein is greater than 90% as determined by reducing SDS-PAGE. |
| Application | WB |
| Recommended Dose | WB: 1:500-2000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Subcellular Localization | Virion membrane ; Single-pass type I membrane protein ; Host endoplasmic reticulum-Golgi intermediate compartment membrane ; Single-pass type I membrane protein ; Host cell membrane ; Single-pass type I membrane protein ;Note: Accumulates in the endoplasmic reticulum-Golgi intermediate compartment, where it participates in virus particle assembly. Colocalizes with S in the host endoplasmic reticulum-Golgi intermediate compartment. Some S oligomers are transported to the host plasma membrane, where they may mediate cell-cell fusion. |
| Construction | Recombinant Antibody |
| Purification | Protein A purified |
| Appearance | Liquid |
| Formulation | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Research Background | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |
| Immunogen | Recombinant Protein: SARS-CoV-2 Nucleocapsid Protein |
| Biology Area | SARS Coronavirus |
Stability & Storage
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930) | purchase Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930) | Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930) cost | order Anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid, WT & Ormicron Recognized Antibody (6F930)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.